RxDoctor Payments Data

Katherine Jackson

Surgical Oncology · Seattle, WANPI 1679952436

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for surgical oncology clinicians in WA, where the typical reported total is $5,112.

$1,355in general payments, 2019–2025

Across 16 payments — averaging $84.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$295
  • Integra Lifesciences Corporation$288
  • Stryker$267
  • Endomagnetics Ltd$197
  • Novo Nordisk$120
  • Intuitive Surgical$91
  • plus $96 from 2 others

What the payments were for

  • Food & beverage$1,355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew4$295
Integra Lifesciences Corporation2$288
Stryker4$267
Endomagnetics Ltd1$197
Novo Nordisk1$120
Intuitive Surgical2$91
Conmed Corporation1$76
Sirius Medical Systems1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,355 in reported general payments places this provider in the 30th percentile of 31 surgical oncology providers in Washington.

See all surgical oncology providers in Washington

Medicare billing

Part B allowed, 2024
$8,987
Medicare patients
23
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →